Ultra-Large Volume Wearable Injectors Market by Product Type (Electromechanical Wearable Injector, and Others) and Application (Diabetes, Cancer, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
- ALL3815960
- 197 Pages
- February 2020
- Medical Devices
Ultra large volume wearable injectors are devices specially designed to stick to the body. These devices work on different mechanisms to deliver drug to the patient through subcutaneous route over an extended period of time. Furthermore, these devices have drug reservoirs that can store drugs solution of 2ml or more then 2ml. For instance, these devices function on mechanisms such as electromechanical, mechanical, and others. In addition, the electromechanical devices work with the help of electrical motor, which is responsible to build pressure for drug delivery. However, mechanical devices use osmosis to deliver the drug to the body of the patient. Furthermore, there are different benefits associated with the use of these devices. These include better patient compliance as this eliminates the need of frequent drug administration, easy ambulation as the patient is not tethered to an IV line, self-administration which lowers the frequency of healthcare professional visits, and others. In addition, these devices are used for the treatment of various chronic conditions such as cancer, diabetes, Parkinson’s diseases, and others.
The major factor that contributes toward the growth of the ultra large volume wearable injectors market include surge in prevalence of chronic disorders such as diabetes, cancer, and others. Furthermore, other factors such as benefits associated with the use of ultra large volume wearable injectors and rise in adoption of these devices across the globe fuel the growth of the market.
Moreover, surge in the demand of more advanced treatment options for chronic diseases such as diabetes contributes toward the growth of the market. In addition, increase in focus by key players toward launch of new products in the market has led to rise in collaborations within the market, which fuels the growth of the market. However, high price of ultra large volume wearable devices restrict the global ultra large volume wearable injectors market growth. In contradiction, presence of ultra large volume wearable devices in development phase, which are expected to be introduced during the forecast period is expected to provide lucrative opportunities for the players in the market.
The ultra large volume wearable injectors market is segmented on the basis of product type, application, and region to provide a detailed assessment of the market. By product type, the market is divided into electromechanical wearable injectors and others. By application, it is classified into diabetes, cancer and others. By region, the ultra large volume wearable injector market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major players operating in the market include Amgen Inc., Becton, Dickinson And Company, CeQur SA, Enable Injections, Inc., Gerresheimer AG (Sensile Medical AG), Insulet Corporation, Medtronic plc., Tandem Diabetes Care, Inc., West Pharmaceutical Services, Inc., and Ypsomed Holding AG.
KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global antihypertensive market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
• By Product Type
o Electromechanical Wearable Injectors
o Others
• By Application
o Diabetes
o Cancer
o Others
• By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
List of key players profiled in the report
• Amgen Inc.
• Becton, Dickinson And Company
• CeQur SA
• Enable Injections, Inc.
• Gerresheimer AG (Sensile Medical AG)
• Insulet Corporation
• Medtronic plc.
• Tandem Diabetes Care, Inc.
• West Pharmaceutical Services, Inc.,
• Ypsomed Holding AG
LIST OF OTHER PLAYERS IN THE VALUE CHAIN(These players are not profiled in the report. The same will be included on request.)
• E3D Elcam Drug Delivery Devices.
• Subcuject ApS
1.1. Report description
1.2. Key market segments
1.2.1. List of key players profiled in the report
1.3. Research methodology
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Key forces shaping ultra large volume wearable injectors industry/market
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of chronic disorders which require the use of ultra large volume wearable injectors for treatment
3.4.1.2. Surge in adoption of ultra large volume wearable injectors across the globe
3.4.1.3. Benefits associated with the use of ultra large volume wearable injectors
3.4.2. Restraint
3.4.2.1. High cost of ultra large volume wearable injectors
3.4.3. Opportunity
3.4.3.1. Presence of products in development phase
3.4.4. Impact Analyses
CHAPTER 4: ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Electromechanical Wearable Injector
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis by country
4.3. Others
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country
CHAPTER 5: ULTRA LARGE VOLUME WEARABLE INJECTORS, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Diabetes
5.2.1. Market size and forecast, by region
5.2.2. Market analysis by country
5.3. Cancer
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
CHAPTER 6: ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. ultra large volume wearable injectors market, by product type
6.2.2.1.2. U.S. ultra large volume wearable injectors market, by application
6.2.2.2. Canada
6.2.2.2.1. Canada ultra large volume wearable injectors market, by product type
6.2.2.2.2. Canada ultra large volume wearable injectors market, by application
6.2.2.3. Mexico
6.2.2.3.1. Mexico ultra large volume wearable injectors market, by product type
6.2.2.3.2. Mexico ultra large volume wearable injectors market, by application
6.2.3. North America market size and forecast, by product type
6.2.4. North America market size and forecast, by application
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany ultra large volume wearable injectors market, by product type
6.3.2.1.2. Germany ultra large volume wearable injectors market, by application
6.3.2.2. France
6.3.2.2.1. France ultra large volume wearable injectors market, by product type
6.3.2.2.2. France ultra large volume wearable injectors market, by application
6.3.2.3. UK
6.3.2.3.1. UK ultra large volume wearable injectors market, by product type
6.3.2.3.2. UK ultra large volume wearable injectors market, by application
6.3.2.4. Italy
6.3.2.4.1. Italy ultra large volume wearable injectors market, by product type
6.3.2.4.2. Italy ultra large volume wearable injectors market, by application
6.3.2.5. Spain
6.3.2.5.1. Spain ultra large volume wearable injectors market, by product type
6.3.2.5.2. Spain ultra large volume wearable injectors market, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe ultra large volume wearable injectors market, by product type
6.3.2.6.2. Rest of Europe ultra large volume wearable injectors market, by application
6.3.3. Europe market size and forecast, by product type
6.3.4. Europe market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan ultra large volume wearable injectors market, by product type
6.4.2.1.2. Japan ultra large volume wearable injectors market, by application
6.4.2.2. China
6.4.2.2.1. China ultra large volume wearable injectors market, by product type
6.4.2.2.2. China ultra large volume wearable injectors market, by application
6.4.2.3. Australia
6.4.2.3.1. Australia ultra large volume wearable injectors market, by product type
6.4.2.3.2. Australia ultra large volume wearable injectors market, by application
6.4.2.4. India
6.4.2.4.1. India ultra large volume wearable injectors market, by product type
6.4.2.4.2. India ultra large volume wearable injectors market, by application
6.4.2.5. South Korea
6.4.2.5.1. South Korea ultra large volume wearable injectors market, by product type
6.4.2.5.2. South Korea ultra large volume wearable injectors market, by application
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific ultra large volume wearable injectors market, by product type
6.4.2.6.2. Rest of Asia-Pacific ultra large volume wearable injectors market, by application
6.4.3. Asia-Pacific market size and forecast, by product type
6.4.4. Asia-Pacific market size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil ultra large volume wearable injectors market, by product type
6.5.2.1.2. Brazil ultra large volume wearable injectors market, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia ultra large volume wearable injectors market, by product type
6.5.2.2.2. Saudi Arabia ultra large volume wearable injectors market, by application
6.5.2.3. South Africa
6.5.2.3.1. South Africa ultra large volume wearable injectors market, by product type
6.5.2.3.2. South Africa ultra large volume wearable injectors market, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA ultra large volume wearable injectors market, by product type
6.5.2.4.2. Rest of LAMEA ultra large volume wearable injectors market, by application
6.5.3. LAMEA market size and forecast, by product type
6.5.4. LAMEA market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. BECTON, DICKINSON AND COMPANY
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. INSULET CORPORATION
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. TANDEM DIABETES CARE, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. YPSOMED HOLDING AG
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. ENABLE INJECTIONS, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product portfolio
7.5.4. Key strategic moves and developments
7.6. MEDTRONIC PLC.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. AMGEN INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. GERRESHEIMER AG (SENSILE MEDICAL AG)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. WEST PHARMACEUTICAL SERVICES, INC.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business Performance
7.10. CEQUR SA
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Product portfolio
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
